PLG and breast carcinoma: In the MDA-MB231 breast cancer cells, silencing of ANX II gene abolishes tPA binding, resulting in inhibition of tPA-dependent plasmin generation and suppressed cell motility, demonstrating the importance of ANX II in enhancing cell motility through upregulation of tPA-dependent plasmin generation [23].